Journal of Cardiovascular Medicine (Hagerstown, Md.)最新文献

筛选

英文中文

Improving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view 低左室射血分数患者植入式心律转复除颤器治疗提高心律失常猝死一级预防的适宜性观点

Journal of Cardiovascular Medicine (Hagerstown, Md.) Pub Date : 2016-03-02 DOI: 10.2459/JCM.0000000000000368

M. Disertori, M. Gulizia, G. Casolo, P. Delise, A. Di Lenarda, G. Di Tano, M. Lunati, L. Mestroni, J. Salerno-Uriarte, L. Tavazzi

{"title":"Improving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view","authors":"M. Disertori, M. Gulizia, G. Casolo, P. Delise, A. Di Lenarda, G. Di Tano, M. Lunati, L. Mestroni, J. Salerno-Uriarte, L. Tavazzi","doi":"10.2459/JCM.0000000000000368","DOIUrl":"https://doi.org/10.2459/JCM.0000000000000368","url":null,"abstract":"It is generally accepted that the current guidelines for the primary prevention of sudden arrhythmic death, which are based on ejection fraction, do not allow the optimal selection of patients with low left ventricular ejection fraction of ischemic and nonischemic etiology for implantation of a cardioverter-defibrillator. Ejection fraction alone is limited in both sensitivity and specificity. An analysis of the risk of sudden arrhythmic death with a combination of multiple tests (ejection fraction associated with one or more arrhythmic risk markers) could partially compensate for these limitations. We propose a polyparametric approach for defining the risk of sudden arrhythmic death using ejection fraction in combination with other clinical and arrhythmic risk markers (i.e. late gadolinium enhancement cardiac magnetic resonance, T-wave alternans, programmed ventricular stimulation, autonomic tone, and genetic testing) that have been validated in nonrandomized trials. In this article, we examine these approaches to identify three subsets of patients who cannot be comprehensively assessed by the current guidelines: patients with ejection fraction of 35% or less and a relatively low risk of sudden arrhythmic death despite the ejection fraction value; patients with ejection fraction of 35% or less and high competitive risk of death due to evolution of heart failure or noncardiac causes; and patients with ejection fraction between 35 and 45% with relatively high risk of sudden arrhythmic death despite the ejection fraction value.","PeriodicalId":418977,"journal":{"name":"Journal of Cardiovascular Medicine (Hagerstown, Md.)","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2016-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130617223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 17